BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16539643)

  • 61. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
    Kong HH; Prose NS; Ware RE; Hall RP
    Pediatr Dermatol; 2005; 22(5):461-4. PubMed ID: 16191003
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival.
    Bagnasco SM; Tsai W; Rahman MH; Kraus ES; Barisoni L; Vega R; Racusen LC; Haas M; Mohammed BS; Zachary AA; Montgomery RA
    Am J Transplant; 2007 Aug; 7(8):1968-73. PubMed ID: 17617861
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation.
    Astor TL; Galantowicz M; Phillips A; Palafox J; Baker P
    Am J Transplant; 2009 Feb; 9(2):409-12. PubMed ID: 19067668
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
    Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K
    Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Successful renal transplantation with desensitization in highly sensitized patients: a single center experience.
    Yoon HE; Hyoung BJ; Hwang HS; Lee SY; Jeon YJ; Song JC; Oh EJ; Park SC; Choi BS; Moon IS; Kim YS; Yang CW
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S148-55. PubMed ID: 19194545
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Late acute antibody mediated rejection after nine years of renal transplantation.
    Halim MA; Al-Otaibi T; Al-Waheeb S; Tawab KA; El Kholy O; Nair P; Said T; Narayanan Nampoory MR
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1111-4. PubMed ID: 21060182
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
    Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR
    Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early Steroid Withdrawal Protocol With Basiliximab and Rituximab in ABO-Incompatible Kidney Transplant Recipients.
    Tojimbara T; Yashima J; Shirai H; Yamazaki T; Koyama I; Nakajima I
    Transplant Proc; 2020; 52(6):1705-1708. PubMed ID: 32444132
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
    Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
    Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.
    Melander C; Sallée M; Trolliet P; Candon S; Belenfant X; Daugas E; Rémy P; Zarrouk V; Pillebout E; Jacquot C; Boffa JJ; Karras A; Masse V; Lesavre P; Elie C; Brocheriou I; Knebelmann B; Noël LH; Fakhouri F
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):579-87. PubMed ID: 19261822
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation].
    Materne C; Gerth J; Ott U; Gröne HJ; Wolf G
    Med Klin (Munich); 2009 Aug; 104(8):644-8. PubMed ID: 19701735
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of basiliximab on renal allograft rejection within 1 year after transplantation.
    Lee BM; Oh CK; Jin SH; Kim JH; Kim SJ; Kim H; Shin GT
    Transplant Proc; 2006 Sep; 38(7):2025-8. PubMed ID: 16979988
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-CD20 monoclonal antibody (rituximab) for therapy of CD20-positive nodular lymphocyte-predominant Hodgkin lymphoma in an 10-year-old girl.
    Culić S; Armanda V; Kuljis D; Kuzmic I; Pranic-Kragic A; Jankovic S
    Pediatr Hematol Oncol; 2006 Dec; 23(8):661-6. PubMed ID: 17065142
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation.
    Imamura T; Kinugawa K; Kato N; Kagami Y; Endo M; Kaneko N; Minatsuki S; Muraoka H; Inaba T; Maki H; Hatano M; Doi K; Yao A; Takazawa Y; Ono M; Kyo S; Komuro I
    Int Heart J; 2013; 54(5):328-31. PubMed ID: 24097224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Single-dose rituximab as induction in renal transplantation.
    van den Hoogen MW; Hilbrands LB
    Transplantation; 2010 May; 89(10):1295; author reply 1295. PubMed ID: 20555227
    [No Abstract]   [Full Text] [Related]  

  • 76. Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and IV immunoglobulin therapy.
    Kessler L; Parissiadis A; Bayle F; Moreau F; Pinget M; Froelich N; Cazenave JP; Berney T; Benhamou PY; Hanau D;
    Am J Transplant; 2009 Aug; 9(8):1961-6. PubMed ID: 19522877
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease.
    Pham PT; Wilkinson AH; Gritsch HA; Pham PC; Miller JM; Lassman CR; Danovitch GM
    Transplant Proc; 2002 Jun; 34(4):1178-81. PubMed ID: 12072308
    [No Abstract]   [Full Text] [Related]  

  • 78. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug insight: rituximab in renal disease and transplantation.
    Salama AD; Pusey CD
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):221-30. PubMed ID: 16932428
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection.
    Mulley WR; Hudson FJ; Tait BD; Skene AM; Dowling JP; Kerr PG; Kanellis J
    Transplantation; 2009 Jan; 87(2):286-9. PubMed ID: 19155986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.